Nanostructures, Gastrointestinal Tract, Liver, Bloodstream, Incorporated Drug,
Due to the development and manufacture of nanostructures,
nanodrug delivery has been designed to overcome those challenges.Nanostructures have been reported to have the ability to protect
drugs from gastrointestinal tract degradation and the technology also allows targeted
drug delivery to various areas of the body. The technology enables the delivery of
drugs that are poorly water-soluble and can provide ways to bypass the liver, thereby preventing metabolism from the first pass.
Nanotechnology increases the oral bioavailability of
drugs due to their specialized take-up mechanisms such as absorptive endocytosis and is able to remain in the bloodstream for longer periods of time, releasing the incorporated drug. Peer review applies to the research done when reviewing published papers and grant proposals. This method enables scholars to follow agreed expectations in their field and eliminates the circulation in questionable results, unwarranted statements, incorrect views and personal beliefs. Publications that have not been peer-reviewed by professional scholars and specialists would certainly be treated with cynicism.
High Impact List of Articles
-
The phosphatidyl-inositol 3-kinase/Akt/ mammalian target of rapamycin pathway as a therapeutic target in head and neck cancer
Saad A Khan & Julie E Bauman
Clinical Trail Outcomes: Clinical Investigation
-
The phosphatidyl-inositol 3-kinase/Akt/ mammalian target of rapamycin pathway as a therapeutic target in head and neck cancer
Saad A Khan & Julie E Bauman
Clinical Trail Outcomes: Clinical Investigation
-
Inhaled corticosteroids: the last 5 years
Hengameh H Raissy, H William Kelly
Review: Clinical Trail Outcomes: Clinical Investigation
-
Inhaled corticosteroids: the last 5 years
Hengameh H Raissy, H William Kelly
Review: Clinical Trail Outcomes: Clinical Investigation
-
Surrogate end points: when should they be used?
Geert Molenberghs, Ariel Alonso Abad, Wim van der Elst, Tomasz Burzykowski, Marc Buyse
Review Article: Clinical Investigation
-
Surrogate end points: when should they be used?
Geert Molenberghs, Ariel Alonso Abad, Wim van der Elst, Tomasz Burzykowski, Marc Buyse
Review Article: Clinical Investigation
-
Advances in inflammatory bowel diseases 2012
Abdo M Saad, Stacy A Kahn, Michele Rubin, David T Rubin
Conference Report: Clinical Investigation
-
Advances in inflammatory bowel diseases 2012
Abdo M Saad, Stacy A Kahn, Michele Rubin, David T Rubin
Conference Report: Clinical Investigation
-
Lacosamide as a new add-on therapy for the treatment of partial-onset seizures
Steve S Chung
Review Article: Clinical Investigation
-
Lacosamide as a new add-on therapy for the treatment of partial-onset seizures
Steve S Chung
Review Article: Clinical Investigation
Relevant Topics in Clinical